Sylvie Baier
Overview
Explore the profile of Sylvie Baier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
10
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hoffmann M, Poschenrieder J, Incudini M, Baier S, Fritz A, Maier A, et al.
Nucleic Acids Res
. 2024 Aug;
52(17):10144-10160.
PMID: 39175109
Most heritable diseases are polygenic. To comprehend the underlying genetic architecture, it is crucial to discover the clinically relevant epistatic interactions (EIs) between genomic single nucleotide polymorphisms (SNPs) (1-3). Existing...
2.
Drugst.One - a plug-and-play solution for online systems medicine and network-based drug repurposing
Maier A, Hartung M, Abovsky M, Adamowicz K, Bader G, Baier S, et al.
Nucleic Acids Res
. 2024 May;
52(W1):W481-W488.
PMID: 38783119
In recent decades, the development of new drugs has become increasingly expensive and inefficient, and the molecular mechanisms of most pharmaceuticals remain poorly understood. In response, computational systems and network...
3.
Hoffmann M, Poschenrieder J, Incudini M, Baier S, Fitz A, Maier A, et al.
medRxiv
. 2023 Dec;
PMID: 38076997
Most heritable diseases are polygenic. To comprehend the underlying genetic architecture, it is crucial to discover the clinically relevant epistatic interactions (EIs) between genomic single nucleotide polymorphisms (SNPs). Existing statistical...
4.
Drugst.One - A plug-and-play solution for online systems medicine and network-based drug repurposing
Maier A, Hartung M, Abovsky M, Adamowicz K, Bader G, Baier S, et al.
ArXiv
. 2023 Jun;
PMID: 37332567
In recent decades, the development of new drugs has become increasingly expensive and inefficient, and the molecular mechanisms of most pharmaceuticals remain poorly understood. In response, computational systems and network...